SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-127603
Filing Date
2022-12-16
Accepted
2022-12-16 09:11:35
Documents
15
Period of Report
2022-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232858d1_8k.htm   iXBRL 8-K 25881
2 EXHIBIT 99.1 tm2232858d1_ex99-1.htm EX-99.1 14053
6 GRAPHIC tm2232858d1_ex99-1img01.jpg GRAPHIC 2435
7 GRAPHIC tm2232858d1_8kimg001.jpg GRAPHIC 4789
  Complete submission text file 0001104659-22-127603.txt   231677

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxxgf-20221216.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxxgf-20221216_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxxgf-20221216_pre.xml EX-101.PRE 22596
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2232858d1_8k_htm.xml XML 3432
Mailing Address 500 CUMMINGS CTR., SUITE 4550 BEVERLY MA 01915
Business Address 500 CUMMINGS CTR., SUITE 4550 BEVERLY MA 01915 800-215-1824
LexaGene Holdings Inc. (Filer) CIK: 0001450416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0228
Type: 8-K | Act: 34 | File No.: 000-56456 | Film No.: 221466663
SIC: 3841 Surgical & Medical Instruments & Apparatus